The role of the inflammasome in cardiovascular diseases
Authors:
- 19 March 2014
- journal article
- review article
- Published by Springer Nature in Journal of Molecular Medicine
- Vol. 92 (4) , 307-319
Abstract
Inflammasome is a very important signaling platform sensing a variety of triggers of the innate immune system. Inflammasome promotes the production of important pro-inflammatory cytokines such as IL-1β and IL-18. Tight control of inflammasome activity is, therefore, essential and occurs at multiple levels. The activation of inflammasome pathways is linked to the pathogenesis of various prevalent disorders including cardiovascular disease such as atherosclerosis, ischemic injury, cardiomyopathy, and Kawasaki disease. The study of the inflammasome in the cardiovascular system has led to the identification of important triggers and endogenous modulators, and to the exploration of new treatment strategies based on the inhibition of inflammasome activation or its end products, i.e., IL-1β and IL-18. In summary, the discovery of the inflammasome has greatly advanced our understanding of how the innate immune system interferes with cardiovascular disease development and progression, and targeting inflammasome provides new avenues for the treatment and management of cardiovascular diseases.Keywords
This publication has 155 references indexed in Scilit:
- Intravenous immunoglobulin suppresses NLRP1 and NLRP3 inflammasome-mediated neuronal death in ischemic strokeCell Death & Disease, 2013
- Effects of Interleukin-1 Blockade With Anakinra on Adverse Cardiac Remodeling and Heart Failure After Acute Myocardial Infarction [from the Virginia Commonwealth University-Anakinra Remodeling Trial (2) (VCU-ART2) Pilot Study]The American Journal of Cardiology, 2013
- Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010The Lancet, 2012
- Genome-wide Association and Population Genetic Analysis of C-Reactive Protein in African American and Hispanic American WomenThe American Journal of Human Genetics, 2012
- Inflammasome Activators Induce Interleukin-1α Secretion via Distinct Pathways with Differential Requirement for the Protease Function of Caspase-1Immunity, 2012
- ER stress activates the NLRP3 inflammasome via an UPR-independent pathwayCell Death & Disease, 2012
- Cholesterol, Inflammasomes, and AtherogenesisCurrent Cardiovascular Risk Reports, 2011
- Chemical characterization of pro-inflammatory amyloid-beta peptides in human atherosclerotic lesions and plateletsBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2011
- IL-1 acts on T cells to enhance the magnitude of in vivo immune responsesCytokine, 2011
- Atherosclerosis in ApoE-deficient mice progresses independently of the NLRP3 inflammasomeCell Death & Disease, 2011